- ProQR Therapeutics (NASDAQ:PRQR) announces changes to its management team and key hires:
- Aniz Girach, MD, is joining ProQR in the role of Chief Medical Officer (CMO) and will be reporting to David Rodman, MD, Executive Vice President of R&D. Most recently, Aniz worked as the CMO for Nightstar Therapeutics.
- Tiffany Burt is joining in the role of Vice president, Head of Commercial. Prior to joining ProQR, she served as Vice President, Marketing at Verastem Oncology.
- Lisa Hayes is joining as Vice President of Investor Relations and Corporate Communications. Lisa joins ProQR from Celgene (NASDAQ:CELG), where she was most recently Senior Director of Investor Relations.
- Smital Shah is promoted to Chief Business and Financial Officer. Ms. Shah joined ProQR in 2014 as CFO. Most recently she was at Gilead Sciences (NASDAQ:GILD).
- René Beukema will retire at year-end 2018 as Chief Corporate Development Officer & General Counsel and management board member.
- Robert Cornelisse, Chief People and Organization will also retire at year-end 2018.
- Now read: Starboard Value holds 9.8% stake in Magellan Health
Original article